Vaccines News
-
Japan's NEC forges clinical development of Neoantigen Cancer Vaccine
Vaccines | News | 0 Comment | 05 Mar, 2024
Japan's NEC Corporation, AI and digital tech firm along with Transgene, which develops virus-based immunotherapies for c...Read more
-
Korea's International Vaccine Institute opens country office in Kenya
Vaccines | News | 0 Comment | 05 Mar, 2024
South Korea-based International Vaccine Institute (IVI) will open a Country and Project Office in Kenya dedicated to the...Read more
-
Vaccines | News | 0 Comment | 29 Feb, 2024
Medidata, a subsidiary of Dassault Systèmes, a leading provider of clinical trial solutions for the life sciences...Read more
-
International Vaccine Institute to open Africa Regional Office in Rwanda
Vaccines | News | 0 Comment | 28 Feb, 2024
South Korea-based International Vaccine Institute (IVI), and the Ministry of Health of Rwanda have announced that IVI wi...Read more
-
Vaccines | News | 0 Comment | 27 Feb, 2024
Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...Read more
-
Korea's SK bioscience obtains WHO prequalification for typhoid conjugate vaccine
Vaccines | News | 0 Comment | 27 Feb, 2024
SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...Read more
-
US-based VBI Vaccines sells manufacturing capabilities to China's Brii Biosciences for $33 M
Vaccines | News | 0 Comment | 16 Feb, 2024
US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...Read more
-
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region
Vaccines | Opinion | 0 Comment | 30 Jan, 2024
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...Read more
-
GSK Australia announces regulatory approval of respiratory syncytial virus vaccine AREXVY
Vaccines | News | 0 Comment | 19 Jan, 2024
GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...Read more
-
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia
Vaccines | News | 0 Comment | 16 Jan, 2024
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...Read more
-
Singapore's Duke-NUS scientists discover potential nasal COVID-19 vaccine candidate
Vaccines | News | 0 Comment | 10 Jan, 2024
A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...Read more
-
CEPI partners with Korean biotech startup Lemonex to advance mRNA vaccine delivery
Vaccines | News | 0 Comment | 05 Jan, 2024
Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...Read more
-
Korea gives license to Euvichol-S, simplified formulation of oral cholera vaccine
Vaccines | News | 0 Comment | 02 Jan, 2024
The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...Read more
-
CEPI and PATH strengthen partnership to accelerate development of vaccines
Vaccines | News | 0 Comment | 19 Dec, 2023
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...Read more
-
Novavax's updated COVID-19 vaccine receives emergency use authorisation in Taiwan
Vaccines | News | 0 Comment | 18 Dec, 2023
American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...Read more
-
Vaccines | News | 0 Comment | 18 Dec, 2023
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...Read more
-
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X
Vaccines | News | 0 Comment | 12 Dec, 2023
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...Read more
-
DxVx plans clinical trials of cancer vaccine in Asia, including Korea and China
Vaccines | News | 0 Comment | 27 Nov, 2023
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...Read more
